Xtx Topco LTD Adaptive Biotechnologies Corp Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.88 - $4.8 $49,063 - $81,772
17,036 New
17,036 $54,000
Q3 2023

Nov 13, 2023
BUY
$5.07 - $8.44 $215,206 - $358,252
42,447 New
42,447 $231,000
Q1 2023

May 12, 2023
BUY
$7.8 - $10.11 $88,241 - $114,374
11,313 New
11,313 $99,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
144M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.11B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email